Balaji Amines Shares Gain On New Plant Approval: SEBI RA Rajneesh Sharma Sees Potential For Over 100% Returns Over 1-2 Years

The stock’s recent price move has mirrored past cycles, with technical and balance sheet trends reinforcing the ongoing breakout.
Representative Image: Getty Images
Representative Image: Getty Images
Profile Image
Deepti Sri·Stocktwits
Updated Jul 02, 2025   |   8:31 PM EDT
Share
·
Add us onAdd us on Google

Shares of Balaji Amines rose nearly 3% on Thursday after the company said it had received consent to operate its Isopropylamine (MIPA/DIPA) manufacturing facility. 

Trial runs are expected to begin shortly, with commercial production to follow.

The stock has rallied nearly 20% in the last one month. 

SEBI-registered analyst Rajneesh Sharma said that the recent move of Balaji Amines shares to ₹1,680 aligns with a historical trendline setup observed in prior cycles, including 2014 and 2020. 

The analyst noted that the long-term logarithmic trendline continues to act as a strong support, with volume patterns suggesting the breakout is still in its early phase.

Sharma pointed to Balaji Amines’ balance sheet improvements over the past five years, citing a drop in borrowings from ₹260 crore to ₹11 crore.

He also noted a rise in reserves from ₹652 crore to ₹1,839 crore, enabled by over ₹1,100 crore in capex, largely funded through internal accruals.

Key business drivers being tracked include the ramp-up of DME, DMC, and NBPT capacities, as well as backward integration through BSCL to reduce raw material costs. 

The analyst added that while methanol prices pose a near-term risk to margins, the broader structural thesis remains intact.

A target range of ₹2,800–₹3,900 over 12–24 months has been maintained, contingent on volume confirmation and a continuation of the current technical setup.

On Stocktwits, retail sentiment was ‘bullish’ amid ‘high’ message volume.

balaji amines ss.jpg
BALAMINES sentiment and message volume as of June 26, 12.30 pm IST. Source: Stocktwits.

The stock has declined 4.6% so far in 2025.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share
·
Add us onAdd us on Google
Read about our editorial guidelines and ethics policy